Hosted on MSN10mon
Sanofi to invest over €1 billion in French production sitesHealthcare company Sanofi (NASDAQ:SNY) to invest more than €1 billion to create new bioproduction capacity at three of its French sites, it said on Monday. These investments at Vitry ...
À Vitry-sur-Seine, Sanofi investira un milliard d’euros pour construire une nouvelle usine qui permettra de doubler la capacité de production d’anticorps monoclonaux sur le site », indique le groupe ...
Sanofi has shared a deeper dive into its 469 million euro ($491 million) bowel disease bet, publishing phase 2 data that provide a clearer look at how the Teva-partnered prospect compares to Merck ...
Sanofi will invest more than €1 billion ($ ... The latest tranche of investment – at Vitry-sur-Seine in Val de Marne, Le Trait in Seine-Maritime, and Lyon Gerland in the Rhône region ...
Hosted on MSN10mon
Healthcare Giants Pfizer, AstraZeneca, Sanofi Inject Over $2B To Boost France's Healthcare SectorSeparately, Sanofi SA (NASDAQ:SNY) has an investment of more than €1 billion to create new bioproduction capacity at its sites in Vitry-sur-Seine (Val de Marne), Le Trait (Seine-Maritime ...
Les activités tertiaires iront sur le Campus Sanofi Val de Bièvres, basé à Gentilly, et les activités de laboratoire sur le site R&D de Vitry-sur-Seine, à horizon fin 2023. » Pas de quoi ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback